An Investigation of the Safety and Utility of Treximet in the Treatment of Menstrual Migraine

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Menstrual Migraine
Interventions
OTHER

Diary

"Each subject will be asked to keep a careful headache diary (appendix B) , and in that diary she will record onset and cessation of menstrual flow, days of menstrual headache (and migraine headache, specifically) experienced, days of functionally incapacitating headache experienced, any abortive/symptomatic medications taken, any days of work-related absenteeism (\>4 hrs) related to acute MM headache and any unscheduled visits to a medical facility for acute treatment of MM."

Trial Locations (1)

35233

University of Alabama at Birmingham, Birmingham

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

University of Alabama at Birmingham

OTHER

NCT01578941 - An Investigation of the Safety and Utility of Treximet in the Treatment of Menstrual Migraine | Biotech Hunter | Biotech Hunter